1-4 of 4
therapy naive
Close
Sort by
Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.
https://doi.org/10.1182/hematology.2019001321
Published: 2019
Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 400–405.
https://doi.org/10.1182/asheducation-2017.1.400
Published: 2017
Journal Articles

Nontransplant therapy for bone marrow failure

Danielle M. Townsley, Thomas Winkler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 83–89.
https://doi.org/10.1182/asheducation-2016.1.83
Published: 2016
Journal Articles

Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Approach to Patients with Treatment-Naive or Refractory Chronic-Phase Disease

Catherine C. Smith, Neil P. Shah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 121–127.
https://doi.org/10.1182/asheducation-2011.1.121
Published: 2011